Ladarixin
Product Specifications
CAS Number
849776-05-2
Synonyms
DF 2156A free base
SKU
C03257-5mg
Target
CXCR
Applications
GPCR & G Protein
Additionnal Information
Ladarixin (DF 2156A free base) is a small molecule, orally available, allosteric and non-competitive antagonist of dual CXCR1 and CXCR2. It is able to reduce the acute and chronic neutrophilic influx, and can be used in research of Asthma, Idiopathic Pulmonary Fibrosis, Influenza-A infection and COPD, cutaneous and uveal melanoma conditions.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2127067-01 25 Tests
APC-Linked Anti-Major Histocompatibility Complex Class I B (MHCB) Polyclonal Antibody
Sign In for Pricing
View Details MBS2127067-02 50 Tests
APC-Linked Anti-Major Histocompatibility Complex Class I B (MHCB) Polyclonal Antibody
Sign In for Pricing
View Details MBS2127067-03 100 Tests
APC-Linked Anti-Major Histocompatibility Complex Class I B (MHCB) Polyclonal Antibody
Sign In for Pricing
View Details MBS2127067-04 200 Tests
APC-Linked Anti-Major Histocompatibility Complex Class I B (MHCB) Polyclonal Antibody
Sign In for Pricing
View Details MBS2127067-05 500 Tests
APC-Linked Anti-Major Histocompatibility Complex Class I B (MHCB) Polyclonal Antibody
Sign In for Pricing
View Details MBS2127067-06 5x 500 Tests
APC-Linked Anti-Major Histocompatibility Complex Class I B (MHCB) Polyclonal Antibody
Sign In for Pricing
View Details